Michael John Tomsicek Milestone Pharmaceuticals Inc. (MIST) insider trading activity

Michael John Tomsicek is of Milestone Pharmaceuticals Inc.. Currently has a direct ownership of 15,000 shares of MIST, which is worth approximately $21,750. The most recent transaction as insider was on Oct 19, 2022, when has been sold 15,000 shares (Common Shares) at a price of $5.32 per share, resulting in proceeds of $79,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K

0% 3M change

0% 12M change

Total Value Held $21,750

MICHAEL JOHN TOMSICEK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 19 2022	BUY Open market or private purchase	$79,800 $5.32 p/Share	15,000 Added 50.0%	15,000 Common Shares

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

Chief Financial Officer

ACRV

Acrivon Therapeutics, Inc.

MJT